BioSpace News Archive

Kinarus Therapeutics Holding AG announced the signing of a strategic convertible loan agreement for a CHF 1.5 million investment by ChaoDian Investment Management Co., Ltd., an investment company based in Hangzhou City, China.

Lipocine Inc. announced financial results for the first quarter ended March 31, 2023, and provided a corporate update.

Chemomab Therapeutics, Ltd., a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, announced financial and operating results for the first quarter ended March 31, 2023, and provided a corporate update.

Emergent BioSolutions Inc. announced that its 2023 Annual Meeting of Stockholders will be held in a virtual-only format via live audio webcast on Thursday, May 25, 2023 at 9:00 AM EDT.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel next-generation T cell therapies for patients suffering from solid tumors, announced financial results for the first quarter ended March 31, 2023 and provided a corporate update.

Reviva Pharmaceuticals Holdings, Inc. has presented promising preclinical data on the potential of novel serotonin-dopamine stabilizer brilaroxazine for the treatment of psoriasis at the First International Societies for Investigative Dermatology Meeting in Tokyo, Japan, May 10-13, 2023.

Annovis Bio, Inc. announced first quarter financial results for the period ended March 31, 2023, and reviewed recent accomplishments.

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, reported financial results for the quarter ended March 31, 2023, and provided operational updates.

Pyxis Oncology, Inc., a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported financial results for the quarter ended March 31, 2023, and provided a corporate update.

Instil Bio, Inc. reported its first quarter 2023 financial results and provided a corporate update.